ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

US FDA approves Novartis' gene therapy for rare muscle disorder
The US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular atrophy. Itvisma offers a new option for a broader patient group. The therapy aims to replace a faulty gene crucial for muscle functi
Announcement as on 25 November 2025

Novartis AG Basel Reaches Analyst Target Price
In recent trading, shares of Novartis AG Basel (Symbol: NVS) have crossed above the average analyst 12-month target price of 7.00, changing hands for 7.11/share. When a stock reaches the target an analyst has set, the analyst logically has two ways
Announcement as on 11 November 2025

Novartis To Acquire Avidity Biosciences In Bln Deal
(RTTNews) - Novartis AG (NVS, NOVN.SW) announced that it has entered into a definitive agreement to acquire Avidity Biosciences Inc. (RNA) for .00 per share in cash, valuing the company at approximately .0 billion on a fully diluted basis. The transa
Announcement as on 27 October 2025

In major move, patent of Novartis' blockbuster cardiac drug revoked by India
The Indian Patent Office revoked Novartis' patent for Vymada, a heart failure drug, citing a lack of novelty and inventive step. This decision paves the way for generic versions, potentially lowering treatment costs for Indian patients. Domestic pharmaceut
Announcement as on 16 September 2025

Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver
GLP-1 drugs are taking much oxygen out of the biotechnology trade. However, many investors have been eyeing other areas in the sector, particularly cancer research. Novartis AG (NYSE: NVS) is up over 31% in 2025, and a novel cancer treatment could giv
Announcement as on 09 September 2025

Announcements by Novartis first page | Next page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 781.57
  • 12Day Average: 781.87
  • 20Day Average: 787.11
  • 50Day Average: 818.89
  • 100Day Average: 863.77
  • 150Day Average: 918.1
  • 200Day Average: 892.52

500672 Indicators & signals

Indicator MACD (12,26,9)

784.09, 795.14, -12.54
Indicator MACD is in negative zone

Indicator ADX (14)

34.2, 8.86, 18.06
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
31 Wed Dec 2025 779.00 775.15 to 785.00 -0.17% 0.57 times
30 Tue Dec 2025 780.30 773.00 to 785.20 0.59% 0.8 times
29 Mon Dec 2025 775.70 775.00 to 791.60 -1.26% 0.63 times
26 Fri Dec 2025 785.60 775.00 to 792.40 -0.21% 0.92 times
24 Wed Dec 2025 787.25 780.30 to 789.90 0.56% 0.65 times
23 Tue Dec 2025 782.85 780.00 to 794.95 0.1% 0.56 times
22 Mon Dec 2025 782.05 772.35 to 798.95 -0.87% 1.76 times
19 Fri Dec 2025 788.90 777.00 to 789.00 0.71% 0.81 times
18 Thu Dec 2025 783.30 779.05 to 786.00 1.1% 0.85 times
17 Wed Dec 2025 774.75 773.35 to 783.00 0.35% 0.36 times
16 Tue Dec 2025 772.05 766.25 to 799.85 -2.35% 2.65 times
15 Mon Dec 2025 790.65 788.05 to 808.95 -1.24% 1.69 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top